JP2004525876A - 抗細菌活性を有する新規複素環式化合物、それらの調製方法、およびそれらを含有する薬学的組成物 - Google Patents

抗細菌活性を有する新規複素環式化合物、それらの調製方法、およびそれらを含有する薬学的組成物 Download PDF

Info

Publication number
JP2004525876A
JP2004525876A JP2002552914A JP2002552914A JP2004525876A JP 2004525876 A JP2004525876 A JP 2004525876A JP 2002552914 A JP2002552914 A JP 2002552914A JP 2002552914 A JP2002552914 A JP 2002552914A JP 2004525876 A JP2004525876 A JP 2004525876A
Authority
JP
Japan
Prior art keywords
alkyl
oxazolan
oxo
salt
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002552914A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525876A5 (enExample
Inventor
ナテサン、セルバクマール
ダス、ジャガッタラン
イクバル、ジャベッド
マガディ、シタラム・クマール
マミディ、ナガ・ベンカタ・スリニバサ・ラオ
ラマヌジャム、ラジャゴパラン
サンダラバル、バスカラン
ローレイ、ブラジ・ブシャン
Original Assignee
ドクター・レディーズ・ラボラトリーズ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ドクター・レディーズ・ラボラトリーズ・リミテッド filed Critical ドクター・レディーズ・ラボラトリーズ・リミテッド
Publication of JP2004525876A publication Critical patent/JP2004525876A/ja
Publication of JP2004525876A5 publication Critical patent/JP2004525876A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2002552914A 2000-12-26 2001-12-26 抗細菌活性を有する新規複素環式化合物、それらの調製方法、およびそれらを含有する薬学的組成物 Withdrawn JP2004525876A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1124MA2000 2000-12-26
IN15MA2001 2001-01-15
PCT/IN2001/000227 WO2002051819A2 (en) 2000-12-26 2001-12-26 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
JP2004525876A true JP2004525876A (ja) 2004-08-26
JP2004525876A5 JP2004525876A5 (enExample) 2005-12-22

Family

ID=26324889

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002552914A Withdrawn JP2004525876A (ja) 2000-12-26 2001-12-26 抗細菌活性を有する新規複素環式化合物、それらの調製方法、およびそれらを含有する薬学的組成物

Country Status (21)

Country Link
US (2) US7030148B2 (enExample)
EP (1) EP1345913A2 (enExample)
JP (1) JP2004525876A (enExample)
KR (1) KR20030063472A (enExample)
CN (1) CN1656083A (enExample)
BG (1) BG108022A (enExample)
BR (1) BR0116571A (enExample)
CA (1) CA2433138A1 (enExample)
CZ (1) CZ20031799A3 (enExample)
EE (1) EE200300254A (enExample)
HR (1) HRP20030522A2 (enExample)
HU (1) HUP0302580A2 (enExample)
IL (1) IL156662A0 (enExample)
MX (1) MXPA03005822A (enExample)
NO (1) NO20032926L (enExample)
NZ (1) NZ526716A (enExample)
PL (1) PL363616A1 (enExample)
RU (1) RU2322444C2 (enExample)
SK (1) SK8202003A3 (enExample)
WO (1) WO2002051819A2 (enExample)
YU (1) YU52403A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008530028A (ja) * 2005-02-24 2008-08-07 テバ ファーマシューティカル インダストリーズ リミティド リネゾリッド中間体の調製方法
JP2019519605A (ja) * 2016-05-20 2019-07-11 バグワークス・リサーチ・インコーポレイテッド 抗菌剤として有用な複素環式化合物及びその生成方法

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
AU2002329393B2 (en) 2001-09-11 2008-06-12 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
US20060293315A1 (en) * 2001-12-21 2006-12-28 Dr. Reddy's Laboratories Ltd. Intermediates of novel heterocyclic compounds having antibacterial activity and process for their preparation
US6914058B2 (en) * 2002-01-18 2005-07-05 Dr. Reddy's Laboratories, Limited Antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
US7141561B2 (en) 2002-07-25 2006-11-28 Sanofi-Aventis Deutschland Gmbh Substituted diaryl heterocycles, process for their preparation and their use as medicaments
DE10233817A1 (de) * 2002-07-25 2004-02-12 Aventis Pharma Deutschland Gmbh Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU2003215861A1 (en) * 2003-04-07 2004-11-01 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
AU2004256085B2 (en) * 2003-07-02 2007-12-06 Kyorin, Pharmaceutical Co., Ltd. Cyclopropyl Group Substituted Oxazolydinone Antibiotics and Derivatives Thereof
MXPA06000228A (es) 2003-07-02 2006-06-27 Merck & Co Inc Antibioticos de oxazolidinona sustituidos con un grupo ciclopropilo y derivados de los mismos.
WO2005035528A2 (en) * 2003-10-14 2005-04-21 Dr. Reddy's Laboratories Ltd. Triazole derivatives as antibacterial agents
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
CN101720325B (zh) * 2007-08-06 2013-04-24 上海盟科药业有限公司 用于治疗细菌感染的抗菌邻-氟苯基噁唑烷酮
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
MX2011001872A (es) * 2008-08-18 2011-05-23 Univ Yale Moduladores de mif.
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
MX384300B (es) 2009-02-03 2025-03-14 Merck Sharp & Dohme Llc Forma cristalina del fosfato de dihidrogeno r) -3- (4- (2- (2-metiltetrazol-5-il) piridin-5-il) -3-fluorofenil) -5-hidroximetil oxazolidin-2-ona.
CN101798302B (zh) * 2009-02-06 2014-11-05 上海盟科药业有限公司 抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
WO2014045292A1 (en) * 2012-09-20 2014-03-27 Symed Labs Limited Improved process for the preparation of linezolid intermediate
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2015127316A1 (en) 2014-02-21 2015-08-27 Micurx Pharmaceuticals, Inc. Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны
US12109203B2 (en) 2018-07-25 2024-10-08 Zydus Lifesciences Limited Substituted oxazolidinones for the treatment of mammalian infections
WO2020234636A1 (en) 2019-05-17 2020-11-26 Cadila Healthcare Limited Novel compounds for the treatment of mammalian infections
CN110301433A (zh) * 2019-07-25 2019-10-08 河南精怡达生物科技有限公司 一种含有微量元素组合的猪精液体外常温保存剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987505A (en) * 1958-03-04 1961-06-06 Gen Aniline & Film Corp Compositions of polymeric nu-vinyl-2-oxazolidone and halogens
US3651079A (en) 1968-11-25 1972-03-21 Colgate Palmolive Co 1-aryl-5-hydroxyalkyl-hydantoins
GB1408010A (en) * 1972-11-20 1975-10-01 Geistlich Soehne Ag Sulphamoylphenyl-imidazolidinones
US4174958A (en) 1978-01-09 1979-11-20 Shell Oil Company Anilide derivative herbicides
FR2571364B1 (fr) * 1984-10-09 1987-07-17 Oreal Nouveau procede de preparation de nitroparaphenylenediamines n,n'-disubstituees, nouvelles oxazolidones utilisees dans ce procede, nouvelles nitroparaphenylenediamines n,n'-disubstituees obtenues selon ce procede et compositions tinctoriales contenant les nitroparaphenylenediamines n,n'-disubstituees obtenues selon ledit procede
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
DE69522234T2 (de) 1994-10-26 2002-05-16 Pharmacia & Upjohn Co., Kalamazoo Phenyloxazolidinone mit antimikrobieller wirkung
US6124334A (en) 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
GB9601666D0 (en) 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
US6087496A (en) * 1998-05-22 2000-07-11 G. D. Searle & Co. Substituted pyrazoles suitable as p38 kinase inhibitors
JPH11322729A (ja) * 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
CN1367780A (zh) 1999-07-28 2002-09-04 法玛西雅厄普约翰美国公司 噁唑烷酮类化合物、其制备方法及其应用
GB0118407D0 (en) 2001-07-27 2001-09-19 Cipla Ltd Oxazolidinone derivatives as antibacterial agents

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008530028A (ja) * 2005-02-24 2008-08-07 テバ ファーマシューティカル インダストリーズ リミティド リネゾリッド中間体の調製方法
JP2019519605A (ja) * 2016-05-20 2019-07-11 バグワークス・リサーチ・インコーポレイテッド 抗菌剤として有用な複素環式化合物及びその生成方法

Also Published As

Publication number Publication date
HRP20030522A2 (en) 2005-06-30
RU2003123104A (ru) 2005-03-10
NO20032926L (no) 2003-08-25
IL156662A0 (en) 2004-01-04
US20040059120A1 (en) 2004-03-25
US20030065175A1 (en) 2003-04-03
EP1345913A2 (en) 2003-09-24
NZ526716A (en) 2005-08-26
BG108022A (bg) 2004-09-30
CZ20031799A3 (cs) 2004-02-18
US7183301B2 (en) 2007-02-27
MXPA03005822A (es) 2004-05-04
EE200300254A (et) 2003-12-15
CA2433138A1 (en) 2002-07-04
RU2322444C2 (ru) 2008-04-20
CN1656083A (zh) 2005-08-17
KR20030063472A (ko) 2003-07-28
NO20032926D0 (no) 2003-06-25
YU52403A (sh) 2006-03-03
PL363616A1 (en) 2004-11-29
WO2002051819A9 (en) 2003-08-07
HUP0302580A2 (hu) 2003-11-28
US7030148B2 (en) 2006-04-18
BR0116571A (pt) 2004-03-02
WO2002051819A2 (en) 2002-07-04
WO2002051819A3 (en) 2002-12-05
SK8202003A3 (en) 2004-07-07

Similar Documents

Publication Publication Date Title
US7030148B2 (en) Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
KR100340365B1 (ko) 옥사졸리디논유도체및이들을함유하는약학조성물
KR20020067557A (ko) 설폭시민 관능기를 가지는 옥사졸리디논 및항미생물제로서의 그의 용도
HUT72296A (en) Oxazolidinones containing a substituted diazine moiety and pharmaceutical compositions containing them having antimicrobial effect
WO2005005398A2 (en) Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof
JP5662940B2 (ja) 新規な抗微生物薬
US20040077626A1 (en) Difluorothioacetamides of oxazolidinones as antibacterial agents
US7160912B2 (en) Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
WO2009001192A2 (en) Novel compounds and their use
US20040072873A1 (en) N-Aryl-2-oxazolidinones and their derivatives
JP2006504726A (ja) 抗菌性1−アリールジヒドロピリドン化合物
AU2002226669A1 (en) Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
WO2004087697A1 (en) N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity
US20070004712A1 (en) Salts of novel heterocyclic compounds having antibacterial activity
US20040072842A1 (en) Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent
WO2006018682A2 (en) Oxazolidinone derivatives as antimicrobials
US20100234390A1 (en) Novel compound and their use
WO2006051408A1 (en) Oxazolidinone derivatives as antimicrobials
ZA200304945B (en) Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041224

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20080327